DNA-dependent protein kinase (DNA-PK) as a potential therapeutic target in non-small lung cancer cell lines (NSCLC)

被引：0
|
作者：
Sak, A. [1 ]
Groneberg, M. [1 ]
Stuschke, M. [1 ]
机构：
[1] Uniklinikum Essen, Strahlenklin, Essen, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2013年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：123 / 123
页数：1
相关论文
共 50 条
  • [31] DEVELOPMENT OF DNA-DEPENDENT PROTEIN-KINASE (DNA-PK) ASSAY SYSTEM USING HUMAN AUTOANTIBODIES AGAINST THE 350-KDA CATALYTIC SUBUNIT OF DNA-PK
    SUWA, A
    MIMORI, T
    WATANABE, F
    TERAOKA, H
    HIRAKATA, M
    INADA, S
    HARDIN, JA
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 1001 - 1001
  • [32] Chromium-mediated apoptosis: Involvement of DNA-dependent protein kinase (DNA-PK) and differential induction of p53 target genes
    Hill, Richard
    Leidal, Andrew M.
    Madureira, Patricia A.
    Gillis, Laura D.
    Waisman, David M.
    Chiu, Arthur
    Lee, Patrick W. K.
    DNA REPAIR, 2008, 7 (09) : 1484 - 1499
  • [33] Protein palmitoylation in non-small cell lung cancer (NSCLC): DHHC5 palmitoyltransferase as a potential therapeutic target
    Tian, Hui
    Lu, Jui-Yun
    Shao, Chunli
    Huffman, Kenneth
    Carstens, Ryan
    Minna, John D.
    Hofmann, Sandra L.
    CANCER RESEARCH, 2014, 74 (19)
  • [34] DNA-dependent protein kinase (DNA-PK) regulates V(D)J recombination by RAG2 phosphorylation
    Kim, DR
    Choi, Y
    Son, YM
    Hah, YS
    FEBS JOURNAL, 2005, 272 : 290 - 291
  • [35] Atropisomeric 8-arylchromen-4-ones exhibit enantioselective inhibition of the DNA-dependent protein kinase (DNA-PK)
    Cano, Celine
    Golding, Bernard T.
    Haggerty, Karen
    Hardcastle, Ian R.
    Peacock, Marcus
    Griffin, Roger J.
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2010, 8 (08) : 1922 - 1928
  • [36] Preclinical characterization of the selective DNA-dependent protein kinase (DNA-PK) inhibitor VX-984 in combination with chemotherapy
    Boucher, D.
    Hillier, S.
    Newsome, D.
    Wang, Y.
    Takemoto, D.
    Gu, Y.
    Markland, W.
    Hoover, R.
    Arimoto, R.
    Maxwell, J.
    Fields, S. Z.
    Charifson, P.
    Penney, M. S.
    Tanner, K.
    ANNALS OF ONCOLOGY, 2016, 27
  • [37] DNA ligase I activation during repair of alkylation damaged DNA is via DNA-dependent protein kinase (DNA-PK) mediated phosphorylation
    Bhat, KR
    Benton, BJ
    Ray, R
    FASEB JOURNAL, 1999, 13 (07): : A1453 - A1453
  • [38] Preclinical evaluation of DNA-PK as a therapeutic target in prostate cancer
    Dylgjeri, Emanuela
    Goodwin, Jonathan F.
    McNair, Christopher M.
    Shafi, Ayesha A.
    Kothari, Vishal
    Feng, Felix
    Rathkop, Dana
    Knudsen, Karen
    CANCER RESEARCH, 2017, 77
  • [39] A novel, selective inhibitor of DNA-dependent protein kinase (DNA-PK) potentiates the effects of DNA-damaging therapies in hepatocellular carcinoma
    Willoughby, Catherine E.
    Thomas, Huw D.
    Rennison, Tommy
    Cano, Celine
    Reeves, Helen L.
    Wedge, Stephen R.
    CANCER RESEARCH, 2017, 77
  • [40] DNA-dependent protein kinase inhibition radiosensitizes human cervical cancer cell lines
    Zempolich, Karen
    Clark, Erin
    Fuhrman, Christa
    Lacoursiere, D. Yvette
    Soisson, Andrew P.
    Gaffney, David K.
    CANCER RESEARCH, 2006, 66 (08)
12345